You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

retinal ganglion cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Diabetic Retinopathy Trial in Chicago (Melatonin, Placebo)

Recruiting
  • Diabetes Mellitus
  • Diabetic Retinopathy
  • Chicago, Illinois
    University of Illinois at Chicago
May 16, 2022

Open-angle Glaucoma, Diabetic Retinopathy Trial in New York (GlaucoHealth, GlaucoSelect, Placebo)

Terminated
  • Open-angle Glaucoma
  • Diabetic Retinopathy
  • New York, New York
    New York Eye and Ear Infirmary of Mount Sinai
Mar 15, 2021

Opioid Use Disorder, Sleep Disturbance Trial in Birmingham (Post-Illumination Pupillary Response (PIPR), Polysomnography,

Not yet recruiting
  • Opioid Use Disorder
  • Sleep Disturbance
  • Post-Illumination Pupillary Response (PIPR)
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Oct 24, 2023

Glaucoma Trial in Seongnam (Nicotinamide(Mitovita), Placebo)

Recruiting
  • Glaucoma
  • Nicotinamide(Mitovita)
  • Placebo
  • Seongnam, Bundang-gu, Korea, Republic of
    CHA University Bundang Medical Center
Oct 9, 2023

Preparation of Patient Autologous Induced Pluripotent Stem

Not yet recruiting
  • Age-Related Macular Degeneration
  • somatic cell collection
  • (no location specified)
Aug 14, 2023

Eye Abnormalities Trial in Gdansk (Complex product, Polyphenol-rich extracts, Placebo)

Recruiting
  • Eye Abnormalities
  • Complex product
  • +2 more
  • Gdańsk, Poland
    Centrum Zdrowia Eter-Med sp. z o.o.
Aug 21, 2023

Cell Collection to Study Eye Diseases

Recruiting
  • Retinal Disease
  • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 23, 2023

    Glaucoma Trial in Miami (Latanoprost, Bimatoprost, Travoprost)

    Active, not recruiting
    • Glaucoma
    • Miami, Florida
      Bascom Palmer Eye Institute - University of Miami
    Oct 7, 2021

    Retinitis Pigmentosa Trial in Irvine, Los Angeles, Boston (human retinal progenitor cells)

    Completed
    • Retinitis Pigmentosa
    • human retinal progenitor cells
    • Irvine, California
    • +2 more
    Aug 8, 2022

    Multiple Sclerosis Trial in Baltimore (Light therapy)

    Enrolling by invitation
    • Multiple Sclerosis
    • Light therapy
    • Baltimore, Maryland
      Johns Hopkins School of Medicine
    May 2, 2022

    Age-Related Macular Degeneration Trial (Cultured retinal stem and progenitor cells, Standard treatment according to the clinical

    Not yet recruiting
    • Age-Related Macular Degeneration
    • Cultured retinal stem and progenitor cells
    • Standard treatment according to the clinical protocols
    • (no location specified)
    Dec 24, 2021

    Retinitis Pigmentosa Trial in Irvine, Los Angeles, Boston (human retinal progenitor cells, Mock injection)

    Completed
    Has Results
    • Retinitis Pigmentosa
    • human retinal progenitor cells
    • Mock injection
    • Irvine, California
    • +2 more
    Mar 3, 2022

    Retinal Disease, Age-Related Macular Degeneration, Retinitis Pigmentosa Trial in Westport, Coral Springs, Dubai (Arm 1)

    Recruiting
    • Retinal Disease
    • +17 more
    • Arm 1
    • Westport, Connecticut
    • +2 more
    Nov 25, 2022

    Primary Glaucoma Trial (Tropical fruits)

    Not yet recruiting
    • Primary Glaucoma
    • Tropical fruits
    • (no location specified)
    Oct 1, 2023

    Age-related Macular Degeneration Trial in Israel, United States (OpRegen)

    Completed
    • Age-Related Macular Degeneration
    • OpRegen
    • (no location specified)
    Nov 1, 2022

    Non-exudative Age-related Macular Degeneration, Diabetic Retinopathy, Retina Vein Occlusion Trial in Sacramento (CD34+ bone

    Enrolling by invitation
    • Non-exudative Age-related Macular Degeneration
    • +4 more
    • CD34+ bone marrow stem cells intravitreal
    • Sacramento, California
      University of California Davis
    Aug 8, 2022

    Primary Open-Angle Glaucoma Trial in Izmir, Manisa (GlaucoT Glaucoma Treatment Device)

    Recruiting
    • Primary Open-Angle Glaucoma
    • GlaucoT Glaucoma Treatment Device
    • İzmir, Turkey
    • +1 more
    Mar 19, 2022

    Best Disease and Other Retinal Degenerative Diseases.

    Active, not recruiting
    • Retinal Disease
    • +4 more
      • Rochester, Minnesota
        Mayo Clinic
      Jan 4, 2022

      Calretinin and Function of Ganglion Cells in Hirschsprung

      Recruiting
      • Hirschsprung Disease
      • +3 more
      • Calretinin staining
      • Montréal, Quebec, Canada
        CHU Sainte-Justine
      Mar 15, 2021

      Glaucoma Trial in Paris (Electroretinogram Pattern (Diopsys® NOVA System))

      Active, not recruiting
      • Glaucoma
      • Electroretinogram Pattern (Diopsys® NOVA System)
      • Paris, France
        Groupe Hospitalier Paris Saint-Joseph
      Jun 29, 2022

      Primary Open Angle Glaucoma Trial in Roma, Rome (Citicoline, Placebo)

      Recruiting
      • Primary Open Angle Glaucoma
      • Citicoline
      • Placebo
      • Roma, Italy
      • +1 more
      Mar 29, 2022

      Production of iPSC Derived RPE Cells for Transplantation in AMD

      Completed
      • Age Related Macular Degeneration (AMD)
        • (no location specified)
        Apr 4, 2022

        Atrophy of Macula GCC by OCT and Whole Brain Atrophy by MRI to

        Active, not recruiting
        • Multiple Sclerosis
        • Brain MRI
        • +2 more
        • Nîmes, France
          CHU de Nimes
        Jan 6, 2022

        Macular Damage in Early Glaucoma and Progression

        Recruiting
        • Glaucoma
          • New York, New York
            CUIMC Harkness Eye Institute
          Nov 4, 2022

          Human iPSC for Repair of Vasodegenerative Vessels in Diabetic

          Recruiting
          • Diabetes Complications
          • Diabetic Retinopathy
          • Generation of inducible pluripotent stem cells
          • Birmingham, Alabama
            University of Alabama at Birmingham
          May 17, 2022